BMY - BRISTOL MYERS SQUIBB CO
60.28
0.470 0.780%
Share volume: 8,982,017
Last Updated: 03-13-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$59.81
0.47
0.01%
View ratios
| Fiscal Date | 12-31-2023 | 12-31-2023 | 03-31-2024 | 03-31-2024 | 06-30-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2023 | Q4 2023 | Q1 2024 | Q1 2024 | Q2 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 02-12-2025 | 02-13-2024 | 04-25-2024 | 04-25-2024 | 07-26-2024 | 07-26-2024 | 10-31-2024 | 02-12-2025 | |
| Total revenue | 11.477 B | 11.477 B | 11.865 B | 11.865 B | 12.201 B | 12.201 B | 11.892 B | 12.342 B | |
| Cost of revenue | 3.345 B | 2.745 B | 15.881 B | 2.932 B | 3.399 B | 3.267 B | 3.219 B | 4.842 B | |
| Gross profit | 8.132 B | 8.732 B | -4.016 B | 8.933 B | 8.802 B | 8.934 B | 8.673 B | 7.500 B | |
| 7.38% | -145.99% | 322.44% | -1.47% | 1.50% | -2.92% | -13.52% | |||
| Operating expenses | 4.551 B | 4.551 B | 5.062 B | 5.062 B | 4.827 B | 4.827 B | 4.357 B | 5.327 B | |
| Selling general and admin | 2.073 B | 2.073 B | 2.367 B | 2.367 B | 1.928 B | 1.928 B | 1.983 B | 2.136 B | |
| Research and development | 2.478 B | 2.478 B | 2.695 B | 2.695 B | 2.899 B | 2.899 B | 2.374 B | 3.191 B | |
| Total expenses | 6.829 B | 9.516 B | 7.419 B | 10.351 B | 7.243 B | 10.510 B | 6.763 B | 7.020 B | |
| 39.35% | -22.04% | 39.52% | -30.03% | 45.11% | -35.65% | 3.80% | |||
| Operating income | 1.303 B | 1.961 B | -11.435 B | 1.514 B | 1.559 B | 1.691 B | 1.910 B | 480.000 M | |
| Ebit | 1.674 B | 2.116 B | -11.516 B | 1.616 B | 1.286 B | 1.798 B | 1.676 B | 175.000 M | |
| Pretax income | 1.674 B | 1.674 B | -11.516 B | -11.516 B | 1.286 B | 1.286 B | 1.676 B | 175.000 M | |
| 0.00% | -787.93% | 0.00% | -111.17% | 0.00% | 30.33% | -89.56% | |||
| Income tax | -88.000 M | -88.000 M | 392.000 M | 392.000 M | -398.000 M | -398.000 M | 461.000 M | 99.000 M | |
| Net income basic | 0.000 | 1.762 B | 0.000 | -11.911 B | 0.000 | 1.680 B | 0.000 | 0.000 | |
| -100.00% | 100.00% | -100.00% | |||||||
| Net income | 1.762 B | 1.762 B | -11.908 B | -11.911 B | 1.684 B | 1.680 B | 1.215 B | 76.000 M | |
| 0.00% | -775.82% | -0.03% | 114.14% | -0.24% | -27.68% | -93.74% |